TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Short Bowel Syndrome Drugs Market Report & Forecast 2022-2028

Global and United States Short Bowel Syndrome Drugs Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 11 October 2022
  • Pages :109
  • Formats:
  • Report Code:SMR-7432247
OfferClick for best price

Best Price: $3480

Short Bowel Syndrome Drugs Market Size, Share 2022


Market Analysis and Insights: Global Short Bowel Syndrome Drugs Market

The global Short Bowel Syndrome Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Short Bowel Syndrome Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Short Bowel Syndrome Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Short Bowel Syndrome Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Short Bowel Syndrome Drugs market.

Global Short Bowel Syndrome Drugs Scope and Market Size

Short Bowel Syndrome Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Short Bowel Syndrome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Short Bowel Syndrome Drugs market size by players, by Type and by Sale Channel, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Segment by Sale Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • China Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE

By Company

  • Emmaus Medical
  • Merck
  • Takeda
  • Ardelyx
  • Naia Pharmaceuticals
  • Nutrinia
  • OxThera
  • GLyPharma Therapeutic
  • Sancilio Pharmaceuticals
  • Zealand Pharma

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Short Bowel Syndrome Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Short Bowel Syndrome Drugs, with price, sales, revenue, and global market share of Short Bowel Syndrome Drugs from 2019 to 2022.

Chapter 3, the Short Bowel Syndrome Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Short Bowel Syndrome Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Short Bowel Syndrome Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Short Bowel Syndrome Drugs.

Chapter 13, 14, and 15, to describe Short Bowel Syndrome Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Short Bowel Syndrome Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Short Bowel Syndrome Drugs Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 109 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Short Bowel Syndrome Drugs Product Introduction
1.2 Global Short Bowel Syndrome Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Short Bowel Syndrome Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Short Bowel Syndrome Drugs Sales in Volume for the Year 2017-2028
1.3 United States Short Bowel Syndrome Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Short Bowel Syndrome Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Short Bowel Syndrome Drugs Sales in Volume for the Year 2017-2028
1.4 Short Bowel Syndrome Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Short Bowel Syndrome Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Short Bowel Syndrome Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Short Bowel Syndrome Drugs Market Dynamics
1.5.1 Short Bowel Syndrome Drugs Industry Trends
1.5.2 Short Bowel Syndrome Drugs Market Drivers
1.5.3 Short Bowel Syndrome Drugs Market Challenges
1.5.4 Short Bowel Syndrome Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Short Bowel Syndrome Drugs Market Segment by Type
2.1.1 Oral Short Bowel Syndrome Drugs
2.1.2 Tablet Short Bowel Syndrome Drugs
2.2 Global Short Bowel Syndrome Drugs Market Size by Type
2.2.1 Global Short Bowel Syndrome Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Short Bowel Syndrome Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Short Bowel Syndrome Drugs Market Size by Type
2.3.1 United States Short Bowel Syndrome Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Short Bowel Syndrome Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Short Bowel Syndrome Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Sale Channel
3.1 Short Bowel Syndrome Drugs Market Segment by Sale Channel
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Short Bowel Syndrome Drugs Market Size by Sale Channel
3.2.1 Global Short Bowel Syndrome Drugs Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.2.2 Global Short Bowel Syndrome Drugs Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 Global Short Bowel Syndrome Drugs Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
3.3 United States Short Bowel Syndrome Drugs Market Size by Sale Channel
3.3.1 United States Short Bowel Syndrome Drugs Sales in Value, by Sale Channel (2017, 2022 & 2028)
3.3.2 United States Short Bowel Syndrome Drugs Sales in Volume, by Sale Channel (2017, 2022 & 2028)
3.3.3 United States Short Bowel Syndrome Drugs Average Selling Price (ASP) by Sale Channel (2017, 2022 & 2028)
4 Global Short Bowel Syndrome Drugs Competitor Landscape by Company
4.1 Global Short Bowel Syndrome Drugs Market Size by Company
4.1.1 Top Global Short Bowel Syndrome Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Short Bowel Syndrome Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Short Bowel Syndrome Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Short Bowel Syndrome Drugs Price by Manufacturer (2017-2022)
4.2 Global Short Bowel Syndrome Drugs Concentration Ratio (CR)
4.2.1 Short Bowel Syndrome Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Short Bowel Syndrome Drugs in 2021
4.2.3 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Short Bowel Syndrome Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Short Bowel Syndrome Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Short Bowel Syndrome Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Short Bowel Syndrome Drugs Market Size by Company
4.5.1 Top Short Bowel Syndrome Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Short Bowel Syndrome Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Short Bowel Syndrome Drugs Sales by Players (2020, 2021 & 2022)
5 Global Short Bowel Syndrome Drugs Market Size by Region
5.1 Global Short Bowel Syndrome Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Short Bowel Syndrome Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Short Bowel Syndrome Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Short Bowel Syndrome Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Short Bowel Syndrome Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Short Bowel Syndrome Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Short Bowel Syndrome Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Short Bowel Syndrome Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Short Bowel Syndrome Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Short Bowel Syndrome Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Short Bowel Syndrome Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Short Bowel Syndrome Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Emmaus Medical
7.1.1 Emmaus Medical Corporation Information
7.1.2 Emmaus Medical Description and Business Overview
7.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Emmaus Medical Short Bowel Syndrome Drugs Products Offered
7.1.5 Emmaus Medical Recent Development
7.2 Merck
7.2.1 Merck Corporation Information
7.2.2 Merck Description and Business Overview
7.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Merck Short Bowel Syndrome Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Takeda
7.3.1 Takeda Corporation Information
7.3.2 Takeda Description and Business Overview
7.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Takeda Short Bowel Syndrome Drugs Products Offered
7.3.5 Takeda Recent Development
7.4 Ardelyx
7.4.1 Ardelyx Corporation Information
7.4.2 Ardelyx Description and Business Overview
7.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ardelyx Short Bowel Syndrome Drugs Products Offered
7.4.5 Ardelyx Recent Development
7.5 Naia Pharmaceuticals
7.5.1 Naia Pharmaceuticals Corporation Information
7.5.2 Naia Pharmaceuticals Description and Business Overview
7.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
7.5.5 Naia Pharmaceuticals Recent Development
7.6 Nutrinia
7.6.1 Nutrinia Corporation Information
7.6.2 Nutrinia Description and Business Overview
7.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Nutrinia Short Bowel Syndrome Drugs Products Offered
7.6.5 Nutrinia Recent Development
7.7 OxThera
7.7.1 OxThera Corporation Information
7.7.2 OxThera Description and Business Overview
7.7.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 OxThera Short Bowel Syndrome Drugs Products Offered
7.7.5 OxThera Recent Development
7.8 GLyPharma Therapeutic
7.8.1 GLyPharma Therapeutic Corporation Information
7.8.2 GLyPharma Therapeutic Description and Business Overview
7.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Products Offered
7.8.5 GLyPharma Therapeutic Recent Development
7.9 Sancilio Pharmaceuticals
7.9.1 Sancilio Pharmaceuticals Corporation Information
7.9.2 Sancilio Pharmaceuticals Description and Business Overview
7.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Products Offered
7.9.5 Sancilio Pharmaceuticals Recent Development
7.10 Zealand Pharma
7.10.1 Zealand Pharma Corporation Information
7.10.2 Zealand Pharma Description and Business Overview
7.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Zealand Pharma Short Bowel Syndrome Drugs Products Offered
7.10.5 Zealand Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Short Bowel Syndrome Drugs Industry Chain Analysis
8.2 Short Bowel Syndrome Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Short Bowel Syndrome Drugs Distributors
8.3 Short Bowel Syndrome Drugs Production Mode & Process
8.4 Short Bowel Syndrome Drugs Sales and Marketing
8.4.1 Short Bowel Syndrome Drugs Sales Channels
8.4.2 Short Bowel Syndrome Drugs Distributors
8.5 Short Bowel Syndrome Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Short Bowel Syndrome Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Short Bowel Syndrome Drugs Market Trends
Table 3. Short Bowel Syndrome Drugs Market Drivers
Table 4. Short Bowel Syndrome Drugs Market Challenges
Table 5. Short Bowel Syndrome Drugs Market Restraints
Table 6. Global Short Bowel Syndrome Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Short Bowel Syndrome Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Short Bowel Syndrome Drugs Sales by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Short Bowel Syndrome Drugs Sales by Sale Channel: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Short Bowel Syndrome Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Short Bowel Syndrome Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Short Bowel Syndrome Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Short Bowel Syndrome Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Short Bowel Syndrome Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2021)
Table 18. Top Players of Short Bowel Syndrome Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Short Bowel Syndrome Drugs Product Type
Table 20. Date of International Manufacturers Enter into Short Bowel Syndrome Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Short Bowel Syndrome Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Short Bowel Syndrome Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Short Bowel Syndrome Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Short Bowel Syndrome Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Short Bowel Syndrome Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Short Bowel Syndrome Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Short Bowel Syndrome Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Short Bowel Syndrome Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Short Bowel Syndrome Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Short Bowel Syndrome Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Short Bowel Syndrome Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Short Bowel Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Short Bowel Syndrome Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Short Bowel Syndrome Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Short Bowel Syndrome Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Short Bowel Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Short Bowel Syndrome Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Short Bowel Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Short Bowel Syndrome Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Short Bowel Syndrome Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Emmaus Medical Corporation Information
Table 43. Emmaus Medical Description and Business Overview
Table 44. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Emmaus Medical Short Bowel Syndrome Drugs Product
Table 46. Emmaus Medical Recent Development
Table 47. Merck Corporation Information
Table 48. Merck Description and Business Overview
Table 49. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Merck Product
Table 51. Merck Recent Development
Table 52. Takeda Corporation Information
Table 53. Takeda Description and Business Overview
Table 54. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Takeda Product
Table 56. Takeda Recent Development
Table 57. Ardelyx Corporation Information
Table 58. Ardelyx Description and Business Overview
Table 59. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Ardelyx Product
Table 61. Ardelyx Recent Development
Table 62. Naia Pharmaceuticals Corporation Information
Table 63. Naia Pharmaceuticals Description and Business Overview
Table 64. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Naia Pharmaceuticals Product
Table 66. Naia Pharmaceuticals Recent Development
Table 67. Nutrinia Corporation Information
Table 68. Nutrinia Description and Business Overview
Table 69. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Nutrinia Product
Table 71. Nutrinia Recent Development
Table 72. OxThera Corporation Information
Table 73. OxThera Description and Business Overview
Table 74. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. OxThera Product
Table 76. OxThera Recent Development
Table 77. GLyPharma Therapeutic Corporation Information
Table 78. GLyPharma Therapeutic Description and Business Overview
Table 79. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. GLyPharma Therapeutic Product
Table 81. GLyPharma Therapeutic Recent Development
Table 82. Sancilio Pharmaceuticals Corporation Information
Table 83. Sancilio Pharmaceuticals Description and Business Overview
Table 84. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Sancilio Pharmaceuticals Product
Table 86. Sancilio Pharmaceuticals Recent Development
Table 87. Zealand Pharma Corporation Information
Table 88. Zealand Pharma Description and Business Overview
Table 89. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Zealand Pharma Product
Table 91. Zealand Pharma Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Short Bowel Syndrome Drugs Customers List
Table 95. Short Bowel Syndrome Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome Drugs Product Picture
Figure 2. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Short Bowel Syndrome Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Short Bowel Syndrome Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Short Bowel Syndrome Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Short Bowel Syndrome Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Short Bowel Syndrome Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Short Bowel Syndrome Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Short Bowel Syndrome Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Short Bowel Syndrome Drugs Report Years Considered
Figure 11. Product Picture of Oral Short Bowel Syndrome Drugs
Figure 12. Product Picture of Tablet Short Bowel Syndrome Drugs
Figure 13. Global Short Bowel Syndrome Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Short Bowel Syndrome Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Short Bowel Syndrome Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Short Bowel Syndrome Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 17. Global Short Bowel Syndrome Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Short Bowel Syndrome Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 19. United States Short Bowel Syndrome Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Short Bowel Syndrome Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Short Bowel Syndrome Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Short Bowel Syndrome Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 23. United States Short Bowel Syndrome Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Short Bowel Syndrome Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 25. Product Picture of Hospital Pharmacies
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Product Picture of Online Pharmacies
Figure 28. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2022 & 2028
Figure 29. Global Short Bowel Syndrome Drugs Sales in Value by Sale Channel (2017-2028) & (US$ Million)
Figure 30. Global Short Bowel Syndrome Drugs Sales Market Share in Value by Sale Channel (2017-2028)
Figure 31. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028) & (K Pcs)
Figure 32. Global Short Bowel Syndrome Drugs Sales Market Share in Volume by Sale Channel (2017-2028)
Figure 33. Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2028) & (USD/Pcs)
Figure 34. United States Short Bowel Syndrome Drugs Market Share by Sale Channel in 2022 & 2028
Figure 35. United States Short Bowel Syndrome Drugs Sales in Value by Sale Channel (2017-2028) & (US$ Million)
Figure 36. United States Short Bowel Syndrome Drugs Sales Market Share in Value by Sale Channel (2017-2028)
Figure 37. United States Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028) & (K Pcs)
Figure 38. United States Short Bowel Syndrome Drugs Sales Market Share in Volume by Sale Channel (2017-2028)
Figure 39. United States Short Bowel Syndrome Drugs Price by Sale Channel (2017-2028) & (USD/Pcs)
Figure 40. North America Short Bowel Syndrome Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 41. North America Short Bowel Syndrome Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Short Bowel Syndrome Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 45. Europe Short Bowel Syndrome Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Short Bowel Syndrome Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 52. Asia-Pacific Short Bowel Syndrome Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. China Taiwan Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Short Bowel Syndrome Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 63. Latin America Short Bowel Syndrome Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Short Bowel Syndrome Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 68. Middle East & Africa Short Bowel Syndrome Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. UAE Short Bowel Syndrome Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Short Bowel Syndrome Drugs Value Chain
Figure 73. Short Bowel Syndrome Drugs Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount